Article info
PDFEditorial
Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future
- Correspondence to Dr Kim Rajappan, Cardiac Department, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK; kim.rajappan{at}ouh.nhs.uk
Citation
Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future
Publication history
- Received August 15, 2012
- Accepted August 22, 2012
- First published September 28, 2012.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions